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This case report presents a novel ﬁnding of Rectosigmoid Hirschsprung disease in association with Factor
VII deﬁciency in 2 years female presented to King Abdulaziz University Hospital (KAUH). She was
admitted in pediatric surgery unit. On examination; she looked ill and there were signs of infection at the
colostomy site. The infection was treated and her overall health improved in 2 months. Mixing study and
Factor VII level conﬁrmed the presence of Factor VII deﬁciency. Congenital Factor VII deﬁciency is a rare
autosomal recessive disease occurring at a rate of 1:500,000 individuals while Hirschsprung disease (HD)
is found in 1:5000 individuals. The combination of these two disorders is extremely rare. The patient was
successfully managed for both disorders and discharged in good health in stable condition with no
hemorrhagic complication. This case report describes an exceptionally unusual combination of
congenital factor VII deﬁciency and Hirschsprung Disease in same patient.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hirschsprung Disease (HD) is a development disorder of enteric
nervous system which is characterized by aganglionic intestine at
Auerbach plexus and Meissner pleus area. Pathogenesis of HD is
still not fully understood, however various hypothesis are pro-
posed. Multiple congenital abnormalities are present in approxi-
mately 30% of patients. HD is genetically heterogeneous, with
twelve genes involved so far [1]. The RET proto-oncogene on
chromosome 10q11 is the major disease causing gene for non
syndromic HD. Mutations in RET gene are responsible for 50% of
familial HD cases and 15e20% of sporadic cases. HD has been
associated with several chromosomal abnormalities and mono-
genic conditions, including trisomy 21, MowateWilson, Smith
LemlieOpitz and GoldbergeShprintzen syndromes [2]. Hirsch-
sprung disease is also associated with SOX10 mutations. Hirsch-
sprung disease appears to have a dominant pattern of inheritance,
with incomplete penetrance.
Factor VII is one of the coagulation proteins involved in bloodKing Fahd Medical Research
dah 21589 Saudi Arabia.
.
Inc. This is an open access article uclotting. Factor VII deﬁciency is a congenital coagulopathy occur-
ring at prevalence rate of 1:500,000. It has an autosomal recessive
pattern of inheritance. Factor VII deﬁciency can also be acquired
due to antibiotic, vitamin K deﬁciency and liver disease.
Hirschsprung disease, congenital megacolon disease is treated
surgically. However, surgical correction has always been considered
as a hemostatic challenge and in presence of congenital Factor VII
deﬁciency, risk of bleeding is compounded. The co-occurrence of
Hirschsprung disease (HD) and Factor VII in the same person is very
rare.
2. Case report
This study was conducted at the King Abdulaziz University,
Jeddah, Saudi Arabia. Prior to the start of the study an informed
written consent was taken from the patient according to Helsinki
declaration. The consent letter is attached in the manuscript ﬁle.
The study was also approved from ethical committee of the King
Abdulaziz University.
A 2 years old female was admitted to King Abdulaziz University
Hospital (KAUH), with history of Hirschsprung disease. She was
born by spontaneous vaginal delivery (SVD) at full term in another
hospital. At the ﬁrst day of life she had acute abdominal distension,
which deteriorated on the second day to develop perforation. Ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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perforations. She had excessive bleeding post operative and
required blood transfusion. Resection of the segment with multiple
perforation of the part of bowel was done and exteriorization of
both proximal & distal part of the colon was done as well. The
patient was stabilized with colostomy tube and referred to the
pediatric surgery clinic at KAUH. She was the product of SVD, and
there was no similar family history. On physical examination the
child wasmalnourished and underweight with signs of infection on
the colostomy site. Following improvement of the nutritional status
of the patient, surgical correction was planned. Standard preoper-
ative laboratory tests were obtained. Shewas found to have isolated
prolongation of prothrombin time (PT) of 29.4 (reference range
11e14), Elevated International Normalized Ratio was 2.5 (reference
range 0.8e1.3), a normal activated partial thromboplastin time
(APTT) of 31.5 s (Reference range 29e40) and platelet count of 363
(reference range 150e450 *109/L) Factor VII was 8.3% (Reference
range 70e120%). (Table 1).
Mixing study and Factor VII level conﬁrmed the presence of
Factor VII deﬁciency. Other causes of acquired FVII deﬁciency
including liver disease, vitamin K deﬁciency were excluded. The
parents were non-consanguineous and factor VII levels were below
normal range for both parents (44% in the father and 39% in the
mother), consistent with heterozygote state. There is no history of
abnormal bleeding in the family.
Hemostasis was maintained by giving Factor VII concentrate,
aiming for 50% correction before surgery.
During surgery, swenson's pullthrough was done. There was no
excessive bleeding and tissue biopsy conﬁrmed Hirschsprung dis-
ease. Post operative intravenous Recombinant factor VII was given
every 4e6 hourly to maintain at the range of 40e70% for 5 days.
During post operative care there was no evidence of excessive
bleeding from colostomy tube drains. On day 5 patient was
conscious and receiving normal oral nutrition and she was sent
home. Patient was followed up in both haematology and surgical
clinic with no new complaints and she was gaining weight.3. Discussion
Hirschsprung disease (HD)(MIM # 142623) is an intestinal
congenital gut motility disorders affecting one in every 5000 live
births, with fourfold male dominance [3]. Detailed study of prev-
alence of HD in Europe has shown that the incidence of HD recor-
ded in 1980 (1.04 per 10,000) is increased in 2009 (1.42 per 10,000)
withmale to female ratio of 2.8:1. The increase in prevalence can be
attributed to progress in the diagnostic tools. Prevalence studies for
HD carried out in United states, United Kingdom and Columbia was
between 1.63 and 2.26/10,000 live birth [4]. Amiel and Moore have
shown that HD varies from 1.5 in Caucasians to 2.8 in Asians for
every 10,000 newborns [2,5]. In Saudi Arabia, HD was reported in
27 cases of which 66.7% were male and 33.3% were female. The
mean age of presentation was 3 months [6]. Another retrospectiveTable 1








Factor VII level 8.3% 39%
a Prothrombin time.
b Activated Partial Thromboplastin Time.studies on congenital malformation of gastrointestinal tract carried
out in Saudi Arabia, have documented incidence of HD of 1%
(14cases) out of total 1386 cases [7].
HD has complex pattern of inheritance, which describes sex
dependent penetration with 10 genes and 2 loci involved, of which
tyrosine kinase receptor is the major gene. The most frequent ge-
netic impairment is in rearranged during transfection (RET)proto-
oncogene and endothelin receptor B (ENDRB) gene [8]. In 90% of the
patients are HD is diagnosed by delayed passage of meconium,
while some cases are diagnosed later in life due to chronic con-
stipation. .HD may be either short aganglionic (S-HSCR) mostly in
sigmoid colon, long aganglionic (L-HSCR) segment or total colonic
aganglionosis (TCA). Expression of HD in a set of monozygous with
HD, born to unrelated Arab parents, showed autosomal dominant
gene with incomplete penetration.
The factor VII deﬁciency was simultaneously observed in the
same patient. The combination of two rare diseases is unusual.
Factor VII plays a fundamental role in coagulation cascade and its
deﬁciency is rare with the incidence of 1 in 500,000 [9]. It is
characterized by molecular and clinical heterogeneity and has an
autosomal recessive pattern of inheritance. Factor VII gene is
located on chromosome 13 and is 13 kb in size, 2.8 Kb upstream of
Factor  gene. Deﬁciency of Factor VII can range from mild to most
severe bleeding episode due to clinical heterogeneity attributed to
different mutations. Treatment options include; plasma derived
FVII concentrates and recombinant activated FVII (rFVIIc) as per
guidelines for the management of FVII deﬁciency. (Australian,
WFH).
A retrospective study over 8 years on hereditary bleeding dis-
orders in Riyadh, Saudi Arabia included 168 patients of which only
one had VII deﬁciency [10]. Furthermore another retrospective
study from the western region of Saudi Arabia over 11 years re-
ported the prevalence of inherited bleeding disorders reported one
case of factor VII deﬁciency [11].
Consanguineous marriages are the root cause of high incidence
of congenital defects in Saudi Arabia.4. Conclusion
This case report describes a rare novel of congenital factor VII
deﬁciency and Hirschsprung Disease in same patient. Hirschsprung
disease was successfully corrected without excessive bleeding by
maintaining an appropriate hemostatic level of factor VII, preop-
eratively and postoperatively. Epidemiological study in Saudi Ara-
bia could provide insight of both these disorders, considering the
high rate of consanguinity.Conﬂict of interest
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